Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Vaccines Horizon* (1960 to 2010)
Figure 4-1: Global - Vaccine Market (in Billion US$), 2003-2006E
Figure 4-2: Global - Forecast for Vaccine Market (in Billion US$), 2007-2010
Figure 5-1: Global - Vaccine Market Segmentation by Region (%), 2005
Figure 5-2: Global - Sales Split of Major Vaccine Player by Region (%), 2004
Figure 5-3: US - Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
Figure 5-4: US - Pediatric Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
Figure 5-5: US - Hepatitis Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-6: US - Biodefense Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-7: US - Influenza Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-8: US - Travel Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-9: US - Developmental Vaccine Market (in Million US$), 2008E & 2013E
Figure 5-10: Europe - Vaccine Market (in Billion US$), 2005, 2006E, 2008E & 2012E
Figure 5-11: Japan - Influenza Vaccine Production (in Million Units), 2004-05, 2005-06 & 2006-07E
Figure 5-12: China - Vaccine Market (in Billion RMB) 2004-2006E
Figure 5-13: China - Forecast for Vaccine Market (in Billion RMB) 2007-2010
Figure 5-14: India - Vaccine Market (in Million US$) 2004-05 to 2008-09E
Figure 5-15: India - Share of Public & Private Sectors in Vaccine Market (%), Nov 2006
Figure 5-16: India - Top 6 Selling Drugs in Vaccine Market (in Rs Crore), 2005-06
Figure 5-17: India - Share of Domestic Consumption & Exports in Vaccine Market (%), 2005-06
Figure 5-18: Brazil - Vaccine Market (in Million BRL), 2000, 2004, 2006E & 2008E
Figure 5-19: Brazil - Share of Public & Private Sectors in Vaccine Market (%), 2000
Figure 5-20: Global - Vaccine Market by Segment (in Billion US$), 2005, 2006E & 2010E
Figure 5-21: Global - Share of Vaccine Market by Segment (%), 2005, 2006E & 2010E
Figure 5-22: Global - Basic Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-23: Global - Forecast for Basic Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-24: Global - Enhanced Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-25: Global - Forecast for Enhanced Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-26: Global - Proprietary Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-27: Global - Forecast for Proprietary Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-28: Global - Adult/Travel Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-29: Global - Forecast for Adult/Travel Vaccine Market (in Billion US$), 2007-2010
Figure 5-30: Global - Therapeutics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-31: Global - Forecast for Therapeutics Vaccine Market (in Billion US$), 2007-2010
Figure 5-32: Global - Cancer Vaccine Market (in Billion US$), 2005, 2008E & 2010E
Figure 5-33: Global - Addiction Vaccine Market (in Million US$), 2008E & 2010E
Figure 5-34: Global - Influenza Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-35: Global - Share of Influenza Vaccine Production by Manufacturer (%), 2006
Figure 5-36: Global - Forecast for Influenza Vaccine Market (in Billion US$), 2007-2010
Figure 6-1: Global - Pneumococcal Vaccine Market (in Billion US$), 2006 & 2010E
Figure 6-2: Global - Number of Polio Incidences (2004-2006)
Figure 6-3: Global - Countries with Maximum Number of Polio Incidences, 2006
Figure 6-4: Global - Polio Vaccine Market (in Million US$), 2004 & 2011E
Figure 6-5: Global - Inactivated Polio Vaccine Doses (in Million), 2006 & 2011F
Figure 6-6: Global - Meningitis Vaccine Market (in Billion US$), 2004 & 2010E
Figure 6-7: Global - Forecast for Rotavirus Vaccine Market (in Billion US$), 2010
Figure 6-8: Global - Forecast for Rotavirus Vaccine Market Segmentation by Region (%), 2010
Figure 6-9: Global - Number of Diphtheria Incidences by Region, 2006
Figure 6-10: Global - Number of Pertussis Incidences by Region, 2006
Figure 6-11: Global - Number of nTetanus Incidences by Region, 2006
Figure 6-12: Global - Number of tTetanus Incidences by Region, 2006
Figure 6-13: Global - Share of DTP Combos Market by Player (%), 2004
Figure 6-14: Global - Number of Measles Incidences by Region, 2006
Figure 6-15: Global - Number of Mumps Incidences by Region, 2006
Figure 6-16: Global - Number of Rubella Incidences by Region, 2006
Figure 6-17: Global - Number of Tuberculosis Incidences (in Thousand), 2005
Figure 7-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2005
Figure 7-2: Global - Hepatitis B Vaccine Market (in Million US$), 1999, 2005, 2006 & 2011F
Figure 8-1: Global - Profit Margins of Vaccines, Generics & Branded Drugs (%), 2007E
Figure 8-2: Global - Sources of Financing for Vaccine Market (%), 2001
Figure 8-3: Global - Prevnar Sales (in Million US$), 2003-2006
Figure 8-4: US - Drug Discovery Contract Research Organization Market (in Billion US$), 2006E & 2013E
Figure 8-5: Global - Dose Consumption & Revenue by Income of Region (%), 2005
Figure 9-1: Global - Share of Vaccine Market by Player (%), 2005 
 
List of Tables:  

Table 5-1: China - Vaccine Classification
Table 5-2: China - Pediatric Vaccine Requirement (in Million Doses)
Table 5-3: Brazil - Public & Private Sectors Vaccine Market (in Million BRL), 2000
Table 7-1: Global - Number of HIV/AIDS Patients (in Million), 2006
Table 8-1: Global - Number of Deaths due to Diphtheria Averted by Vaccines (in Thousand), 2001
Table 8-2: Global - Cumulative Confirmed Human Cases & Number of Deaths due to Avian Influenza A/ (H5N1), 2003-2007
Table 9-1: Global - Share of Vaccines in Total Pharma Sales of Major Players (%), 2005
Table 9-2: Global - Growth of Vaccines Segment of Major Pharma Players (%), 2005
Table 9-3: Global - Overall Growth of Major Pharma Players (%), 2005
Table 9-4: Global - Major Vaccine Companies (Segmentation by Revenue)
Table 9-5: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
Table 9-6: GlaxoSmithKline Plc. - Key Financials (in Million US$), 2004-2006
Table 9-7: Merck & Co., Inc. - Key Financials (in Million US$), 2004-2006
Table 9-8: Novartis - Key Financials (in Million US$), 2004-2006
Table 9-9: Wyeth - Key Financials (in Million US$), 2004-2006